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Delayed Wound Healing and Epidermal
Hyperproliferation in Mice Lacking JunB in the Skin
Lore Florin1, Julia Knebel1, Paola Zigrino2, Birgitta Vonderstrass1, Cornelia Mauch2, Marina Schorpp-Kistner1,
Axel Szabowski1 and Peter Angel1
The cutaneous response to injury and stress comprises a temporary change in the balance between epidermal
proliferation and differentiation as well as an activation of the immune system. Soluble factors play an
important role in the regulation of these complex processes by coordinating the intercellular communication
between keratinocytes, fibroblasts, and inflammatory cells. In this study, we demonstrate that JunB, a member
of the activator protein-1 transcription factor family, is an important regulator of cytokine expression and thus
critically involved in the cutaneous response to injury and stress. Mice lacking JunB in the skin develop
normally, indicating that JunB is neither required for cutaneous organogenesis, nor homeostasis. However,
upon wounding and treatment with the phorbol ester 12-O-decanoyl-phorbol-13-acetate, JunB-deficiency in the
skin likewise resulted in pronounced epidermal hyperproliferation, disturbed differentiation, and prolonged
inflammation. Furthermore, delayed tissue remodelling was observed during wound healing. These phenotypic
skin abnormalities were associated with JunB-dependent alterations in expression levels and kinetics of
important mediators of wound repair, such as granulocyte macrophage colony-stimulating factor, growth-
regulated protein-1, macrophage inflammatory protein-2, and lipocalin-2 in both the dermal and epidermal
compartment of the skin, and a reduced ability of wound contraction of mutant dermal fibroblasts in vitro.
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INTRODUCTION
Formation and maintenance of the skin epithelium, which
seals the body from the outside world, are obtained through
the tightly controlled balance between proliferation and
terminal differentiation of keratinocytes. As the epidermis is a
frequent target of tissue damage as well as chemical and
mechanical stress, this dynamic equilibrium has perpetually
to be adapted to meet the actual requirements. After
cutaneous wounding, keratinocytes acquire an activated
state in which proliferation is favored over differentiation in
order to replenish the lost material and rapidly close the site
of injury (for a review, see Martin, 1997; Singer and Clark,
1999). Subsequently, tissue architecture within the healing
neo-epidermis has to be re-established, which is achieved by
the switch from keratinocyte proliferation to the apoptosis-
like program of terminal differentiation. The temporally
controlled sequential events occurring during skin regenera-
tion and the cutaneous stress response rely on complex
interactions of many different cell types including keratino-
cytes, fibroblasts, and immune cells. Their concerted actions
are coordinated through the mutual exchange of soluble
cytokines, most of which are not expressed in healthy skin
but are rapidly induced under conditions of tissue challenge
(for a review, see Gillitzer and Goebeler, 2001; Werner and
Grose, 2003).
There is considerable evidence that the transcription factor
activator protein-1 (AP-1) plays an important role in the skin:
involvement in keratinocyte differentiation was suggested as
AP-1 activity is induced during this process (Rutberg et al.,
1996) and binding sites have been mapped within the
promoters of genes encoding keratinocyte-specific proteins
such as keratins as well as the differentiation markers
involucrin, profilaggrin, loricrin, and transglutaminase (for a
review, see Eckert et al., 1997; Angel et al., 2001). In
fibroblasts, expression of extracellular matrix (ECM), compo-
nents such as col1a2, laminin B1 and g2, fibronectin, and
vimentin appears to be controlled by AP-1 (Angel et al.,
2001; Vogt, 2001) and this list could be further elongated in
recent studies using large-scale gene expression profiling
(Leaner et al., 2003; Nowinski et al., 2004; Florin et al.,
2004b). Moreover, various cytokines, such as heparin-
binding epidermal growth factor, granulocyte macrophage
colony-stimulating factor (GM-CSF), keratinocyte growth
factor (KGF) and TGF-b, and proteins involved in cutaneous
wound healing, for example, decorin, tenascin-C, several
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integrins, and matrix metalloproteinases harbor AP-1 sites
within their promoters (for a review, see Benbow and
Brinckerhoff, 1997; Angel et al., 2001; Yates and Rayner,
2002).
The transcription factor AP-1 consists of a variety of homo-
and heterodimers, which are built up by members of the Jun
(c-Jun, JunB, JunD), Fos (c-Fos, FosB, Fra1, Fra2), and ATF
families (AFT2, ATF3, ATF4, ATFa; Shaulian and Karin,
2002). In response to a multitude of extracellular stimuli or
activating oncogenes, AP-1 regulates transcription of different
sets of target genes depending on its subunit composition and
the cellular context (Whitmarsh and Davis, 1996; Mechta-
Grigoriou et al., 2001). Although the use of genetically
engineered mice has provided considerable insight into the
specific functions of individual AP-1 subunits (Jochum et al.,
2001; Hess et al., 2004), little is known about the specific
role of junB in the skin.
During embryonic skin formation, junB expression
starts around E17.5 and was localized in dermal cells
and in basal and granular layers of the epidermis (Wilkinson
et al., 1989; Rutberg et al., 1996; Mehic et al., 2005).
Functional studies in organotypic skin equivalents in vitro
revealed, that junB in dermal fibroblasts modulates prolifera-
tion and differentiation of the keratinocyte epithelium in
trans through paracrine mesenchymal–epithelial interactions
(Szabowski et al., 2000). Loss-of-function approaches
in vivo, however, have been hampered as conventional
gene-targeting results in early embryonic lethality due to
defective placental vascularization (Schorpp-Kistner
et al., 1999). However, junB/Ubi-junB mice, which
express a junB transgene during embryogenesis under
the control of the human Ubiquitin-C promoter (Schorpp-
Kistner et al., 1999; Hartenstein et al., 2002), survive
but were reported to develop a chronic myeloid
leukemia (CML)-like myeloproliferative disease (Passegue
et al., 2001, 2004). Epiblast-specific junB deletion – with
the limitation of possible Cre mosaicism (Tallquist and
Soriano, 2000; Hayashi and McMahon, 2002) – likewise
rescued embryonic lethality (Kenner et al., 2004). Yet,
detailed analyses of the skin of JunB-deficient mice have
not been performed.
In this study, we describe the generation of conditional
JunB knockout mice using Cre/lox-mediated deletion of junB
in tissues expressing Collagen (I)-alpha2-Cre and report on
the characterization of their phenotype during skin develop-
ment and homeostasis as well as during the cutaneous
response to injury and stress.
RESULTS
COL1A2-Cre junB mice overcome embryonic lethality
To investigate the role of JunB in skin development, home-
ostasis, and during tissue regeneration, we generated condi-
tional JunB-deficient mice to circumvent the lethality of
junB/ embryos (Schorpp-Kistner et al., 1999). Mice
harboring floxed junB alleles (junBf/f; Kenner et al., 2004)
or carrying a single floxed and one inactivated junB-Neo
allele (junBf/; Figure 1a) were crossed with COL1A2-Cre
mice, where Cre expression is driven by the Collagen type (I)-
alpha2 promoter (Florin et al., 2004a) starting at E8.5–9.5
(Adamson and Ayers, 1979; Leivo et al., 1980; Khillan et al.,
1986). Conditional COL1A2-Cre junB mutant mice (junBD/D)
were born with Mendelian frequencies and survived to
adulthood. Mutant mice differed from their littermates by
their shaggy fur as well as reduced size and body weight
(Figure S1) reminiscent of animals displaying strongly
reduced junB expression in bone, such as junB/Ubi-junB
(Hess et al., 2003) and Mox2-Cre junBf/f mice (Kenner et al.,
2004). As we never observed any differences between Cre
junBD/D and junBD/ mice, the mutants were comparably
used for the experiments.
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Figure 1. Ubiquitous junB deletion and growth retardation in conditional
junB knockout mice. (a) Schematic representation of mutant junB alleles,
comprising the junB-Neo fusion (), the floxed (f) and deleted (D) loci. The
junB coding sequence is represented by an open box, the start site of
transcription is indicated by an arrow; loxP sites are shown as triangles.
Positions of the probe used for Southern hybridization and the primers for
genotyping (B1, B6, B16, B49) are indicated. A, AccI; E, EcoR1; H, HindIII; P,
PstI; S, SmaI; X, XhoI; Xb, XbaI. (b) Southern blot analysis showing
Cre-mediated ubiquitous junB deletion. A 176 bp PstI/HindIII probe was
used to detect the genomic junB locus digested with PstI. (c) Genomic PCR
confirming complete recombination of the junB allele in the whole skin and
in the bone of junBD/D mice. Positions of oligonucleotide primers are depicted
in (a). (d) Semiquantitative RT-PCR on RNA isolated from the dermis and
epidermis of junB mutant and control animals following TPA treatment.
Collagen type I-alpha2 (co1a2) was used as control for tissue separation.
cDNA levels were standardized to hprt quantities. (e) Immunofluorescence
staining of JunB in TPA-treated skin of control and junB mutant animals,
nuclei were counterstained using Hoechst dye. The residual unspecific signal
in the dermis of junBD/D mice originates from enucleated erythrocytes.
Bar¼100 mm.
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Assessment of the extent of junB recombination in various
organs of conditional junB knockout mice by Southern blot
analysis revealed deletion of the floxed junB allele in all
organs examined (Figure 1b). Furthermore, ubiquitous junB
excision was confirmed by the more sensitive PCR method
with only minor amounts of the unrecombined junB locus
being detectable in the spleen, thymus, and liver (Figure 1c).
Recombination of the junB allele was also detected in
peripheral blood lymphocytes and neutrophil granulocytes
(data not shown). In the skin, the junB gene was completely
recombined in the epidermis and dermis (Figure 1b and c).
Accordingly, neither junB transcripts (Figure 1d) nor JunB
protein (Figure 1e) were detectable in mutant mice, even after
successive applications of the phorbol ester 12-O-decanoyl-
phorbol-13-acetate (TPA) confirming that both, fibroblasts
and keratinocytes of the skin were junB-deficient.
Normal skin development and homeostasis in the absence of
junB
Histological examination of embryonic back skin at E17.5
(Figure 2a), and tail skin of 6-week-old adult mice (Figure 2b)
revealed normal tissue development in junBD/D mice. No
differences in the overall skin architecture of junB mutant and
control mice were observed and the distribution of hair
follicles as well as the number and differentiation of epithelial
layers was not disturbed. Obviously, in junBD/D mice, JunB-
deficiency in both fibroblasts and keratinocytes did neither
impair skin development nor homeostasis, suggesting that
JunB might either not be required for these processes or that
its deletion can be functionally compensated.
TPA-induced hyperproliferation
In 3D-co-cultures of fibroblasts and keratinocytes, we could
demonstrate that the loss of JunB in fibroblasts modulates
keratinocyte growth through paracrine mechanisms resul-
ting in disturbed epithelial differentiation and hyperplasia
(Szabowski et al., 2000). However, these in vitro skin
equivalents do not reflect tissue homeostasis, but rather
represent a model system for wound healing and thus skin
challenge, where AP-1 activity is induced. To investigate
whether also in vivo the cutaneous response to stress was
affected by the loss of JunB, we topically treated the skin of
junBD/D and control mice with the phorbol ester TPA, a strong
inducer of AP-1 activity (Angel and Karin, 1991; Young et al.,
1999; Gallucci et al., 2000).
In junBf/D control mice, three successive applications of
TPA in intervals of 48 hours resulted in a gain in epidermal
thickness (Figure 3) with a concomitant increase in Ki67-
positive proliferating keratinocytes in basal and suprabasal
layers in comparison to untreated animals. However, TPA-
treated skin of junB mutant mice was even thicker, palpably
hardened, and the number of Ki67-positive cells in supraba-
sal layers of the epidermis was further increased. Moreover,
the irregular signal of the keratinocyte differentiation marker
Keratin 10 (K10) indicated disturbances of the differentiation
process. Furthermore, in the dermis of junBD/D mice,
infiltration of neutrophils in response to TPA was enhanced,
whereas the amount of invading macrophages appeared
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Figure 2. Normal skin development and homeostasis in the absence of junB.
(a) Histological sections of embryonic back skin (E17.5) of control (junBf/D)
and junB mutant mice (junBD/D). (b) Examination of tissue architecture in the
tail skin of 6-week-old junBD/D and control animals. Sections were stained
with hematoxylin/eosin (H&E) and immunofluorescence for the epidermal
marker proteins K10 and Keratin 6 was performed. Bar¼ 100mm.
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Figure 3. Analysis of TPA-induced hyperproliferation in junBD/D mice.
Histological examination of solvent (control) and TPA-treated back skin of
conditional junB knockout (junBD/D) and control mice (junBf/D) by staining for
Ki67 and K10 to visualize keratinocyte proliferation and differentiation,
respectively. Staining of neutrophils demonstrated an increased inflammatory
response in TPA-treated skin of junB mutant mice. Bar¼ 100mm.
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similar in mutant and control animals (Figure 3 and data not
shown). Thus, treatment of junBD/D mice led to increased
keratinocyte hyperproliferation and irregular differentiation,
thus recapitulating the phenotype of in vitro skin equivalents
containing junB/ fibroblasts, and enhanced inflammation.
Delayed tissue remodelling in wounded skin of junBD/D mice
In contrast to topical application of phorbol esters, wounding
of the skin represents a physiological stimulus which rapidly
induces AP-1 activity (Martin and Nobes, 1992; Shirai et al.,
2001; Gangnuss et al., 2004). As cutaneous wound healing is
a complex and dynamic process consisting of various
sequential phases (Martin, 1997; Singer and Clark, 1999;
Gillitzer and Goebeler, 2001), the wound repair was care-
fully analyzed over all stages of healing in order to elucidate
the consequences of JunB deletion with respect to quality and
the kinetics of tissue regeneration (Figure 4).
Full-thickness excisional wounds were generated in the
back skin of junB mutant and control mice and the healing
process was analyzed at days 1, 2, 5, 7, 10, 14, 21, and 28
post-injury (nX5 for each time point and genotype). As
already visible macroscopically, wound healing in junBD/D
mice was markedly delayed compared to those of control
littermates (Figure 4). Histological examination revealed
normal keratinocyte migration into the wound field and
subsequent fusion of epithelial leading edges in both wild-
type and junBD/D wounds occurred comparably at days 5–7
(Figure 5a). Yet, wounds of junB mutant mice progressed
markedly later into the final remodelling phase, which is
characterized by an involution of the hyperplastic neoepi-
dermis, wound contraction, and dermal collagen reorganiza-
tion, and did not normalize until day 28. Instead, mutant
epidermis remained hyperplastic for up to 3 weeks (Figure
5b) and the volume of the granulation tissue stayed nearly
constant for at least 4 weeks, as demonstrated by measuring
the area between the flanking hair follicles (Figures 4 and 5c).
An enlargement of the granulation tissue might be
explained by alterations in the composition and remodelling
of the ECM because of differences in the number and/or
activity of myofibroblasts (Tomasek et al., 2002). When we
stained sections with picrofuchsin (Figure S2a) and estimated
the ratio of total collagen versus highly organized collagen
fibers, no major differences in collagen organization were
observed between wounds of knockout mice and their
control littermates. Moreover, the overall cell density within
the granulation tissue was not significantly different between
wild-type and mutant mice and staining of wounds with a-
smooth muscle actin, a marker for differentiated myofibro-
blasts, at days 5–7 (Figure S2b and data not shown) did not
reveal obvious differences in the amount and distribution of
a-smooth muscle actin-positive contractile cells. To directly
compare the ability of this type of cells to reorganize and
contract ECM, primary fibroblasts were isolated from the skin
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Figure 4. Wound healing is delayed in junBD/D mice. The healing process of
4 mm full-thickness excisional wounds in the back skin of junB mutant and
control mice was followed over 28 days (n¼ 3 per genotype and time point,
1–3 wounds of one animal were analyzed). Photomicrographs and
histological sections demonstrated impaired wound healing and epidermal
hyperproliferation following re-epithelialization in junBD/D mice. Wound
edges are indicated by arrowheads. Bar¼1 mm.
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Figure 5. Analysis of the wound healing phenotype. (a) Closure of wounds
from junB mutant and control mice at days 2, 5, and 7 (n¼ 5–7 wounds per
genotype and time point) was judged microscopically and the number of
open wounds was calculated in percent. (b, c) Thickness of the neo-epidermis
(b) and granulation tissue volume (c) of junB mutant (black diamonds) and
control wounds (open diamonds) were quantified and plotted as mean7
standard deviation. (d) Quantification of the cell density within the
granulation tissue of control (white bars) and junB mutant wounds (black bars)
at the indicated days after wounding. Three to five wounds were analyzed per
genotype and time point, bars represent the mean7standard deviation.
(e) Measurement of collagen gel contraction by primary junB mutant and
control fibroblasts. Primary fibroblasts from adult junBD/D and control animals
were cultured in collagen gels and at the indicated time points the gel surface
area was measured (as the average of three random diameters of each gel).
Contraction is indicated as percentage of the initial gel surface area, set
arbitrarily as 100%, of quadruplicate gels. The results represent the
mean7standard deviation of one representative experiment out of three.
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of newborn and 8-week-old mice and tested in 3D collagen I
gels, which is regarded as an in vitro model to determine the
reorganization of connective tissue during wound healing
(Mauch et al., 1988; Tomasek and Akiyama, 1992). Indeed,
dermal fibroblasts from newborn (data not shown) and adult
mutant mice (Figure 5e) exhibited a significantly reduced
capacity to contract collagen lattices, suggesting that in the
absence of junB neither collagen remodelling nor myofibro-
blast differentiation is impaired, but rather defects in
myofibroblast-dependent wound contraction might contri-
bute to the phenotype of delayed wound healing in JunB-
deficient mice.
Loss of junB results in hyperproliferation of the neo-epidermis
In addition to these differences in wound contraction, the
most prominent phenotype in junB mutant mice was the
pronounced hyperplasia of the epidermis between days 7 and
21 post-wounding. In wild-type mice, fusion of the migrating
epithelial edges after wounding was achieved between days
5 and 7. As shown in Figures 5b and 6a, the re-established
epidermis of control mice showed a mild hyperproliferative
phenotype, which decreased around day 10 until epithelial
thickness was reduced to nearly normal levels by day 14. By
contrast, the neoepidermis of junBD/D wounds did not
involute after day 7, was markedly thicker compared to
controls by day 10, and the hyperplasia persisted at least until
day 21 before reaching normal proportions by day 28 post-
wounding (Figures 4 and 5b).
More detailed histological examination of wounds at day
7, when epidermal thickness was still comparable in JunB
mutant and control mice, revealed that already at this stage,
the neoepidermis of junBD/D mice was characterized by an
increased number of proliferating keratinocytes in suprabasal
layers as demonstrated by Ki67 staining (Figure 7a).
Correspondingly, these cells did not express the keratinocyte
differentiation marker K10, which was present only in the
uppermost layers, whereas in control wounds, all suprabasal
layers of the neo-epidermis were K10 positive.
Consequently, 7 days later at day 14 post-wounding, the
epithelium of junBD/D wounds was much thicker compared to
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Figure 6. Epidermal acanthosis and increased neutrophil invasion in junBD/D
wounds. (a) Histological examination of wounds from junBD/D and control
(junBf/D) mice 2 weeks after injury indicates marked epidermal hyperthick-
ening in junBD/D wounds. Keratin 6, K10, and Loricrin were used to mark
hyperproliferation, early, and late keratinocyte differentiation, respectively.
Co-staining using anti-CD68 and anti-neutrophils antibodies revealed
enhanced neutrophil infiltration but equal numbers of macrophages in
wounds of junBD/D mice compared to controls. Bar¼ 100mm.
(b) Quantification of inflammatory cells in 14-day-old wounds of control
(white bars) and junB mutant mice (black bars). The bars represent the
mean7standard deviation of at least three wounds from different animals
per time point and genotype.
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Figure 7. Delayed wound healing correlates with increased keratinocyte
proliferation after epithelial closure of the wound and de-regulated
expression of JunB-dependent cytokines. (a) Sections of 7-day-old wounds
were stained with antibodies for Ki67, K10, and neutrophils to examine
keratinocyte proliferation and differentiation as well as inflammation.
(b) Cytokine expression during wound healing was measured by real-time
PCR on RNA isolated from junBD/D and control wounds at days 0–10 after
injury. Hprt was used as standard and relative mRNA levels compared to
unwounded control skin () were calculated. All experiments were
performed in triplicates, mean values7standard deviation are shown.
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controls and displayed strong expression of Keratin 6, which
is indicative for keratinocyte hyperproliferation (Figure 6a).
Moreover, the area of cells positive for K10 and loricrin was
markedly enlarged in wounds of JunB mutant animals
compared to controls. However at this stage, the regular
suprabasal onset of K10 expression was restored, suggesting
that keratinocyte differentiation had normalized by this time
point concomitant with proliferation being now restricted to
the basal layer.
Persistent inflammation in wounds lacking junB
We next examined, whether the delayed wound healing was
correlated with an altered immune response. As in TPA-
treated skin, immunofluorescence staining for CD68 revealed
no difference in the infiltration of macrophages at any stage of
wound repair (Figure 6a and b and data not shown). By
contrast, the influx of neutrophils was initially delayed in
junBD/D mice with reduced numbers of cells being detectable
in wounds at 6 hours and 1 day post-wounding (data not
shown). At days 2–10, the amount of neutrophils was
comparable in wounds of mutant and control littermates
(Figures 6b and 7a and data not shown). However, while their
numbers decreased and only few cells were detected in the
granulation tissue of controls at day 14, the level of
neutrophils remained elevated in wounds of mutant mice
(Figure 6a and b). Thus, the initially delayed infiltration was
followed by a prolonged presence of neutrophils in the
granulation tissue of junBD/D mice, indicating a longer lasting
inflammation.
Altered expression of cytokines in wounds of junB mutant mice
In organotypic co-cultures, epithelial hyperplasia could be
attributed to the transcriptional de-repression and thus
increased production of JunB-regulated paracrine epithelial
growth factors and cytokines such as KGF and GM-CSF by
the JunB-deficient feeder cells (Szabowski et al., 2000). We
therefore determined whether expression of these genes was
also de-regulated in vivo during wound healing in junBD/D
mice (Figure 7). In addition, we investigated the expression of
additional cytokines including the chemokines macrophage
inflammatory protein-2 (Mip-2/CXCL2), growth-regulated
protein-1 (Gro-1/KC/Mgsa/CXCL1), and the pro-inflammatory
cytokine lipocalin-2 (Lcn-2), which we recently identified as
JunB target genes by microarray analysis of IL-1-treated wild-
type and junB/ fibroblasts (Florin et al., 2004b). Quantita-
tive RT-PCR on cDNAs prepared from control and junBD/D
wounds at different stages of healing revealed that expression
of gm-csf, mip2, gro1, and lcn2 was induced at day 1 after
injury in control wounds. After reaching this maximum post-
wounding, mRNA levels decreased to nearly background
levels after 5 days (Figure 7b). In the absence of JunB, basal
level expression of gm-csf was significantly increased and
highest induction of mip2, gro1, and lcn2 was shifted to later
time points, thus correlating with reduced neutrophil invasion
within the first day of healing. Importantly, after 48 hours, all
four cytokines were hyperinduced in junB-deficient wounds
and expression remained elevated for a prolonged period of
time and did not decrease until day 10 after injury. By
contrast, no significant aberrations were observed in the
expression of Kgf/Fgf7 (data not shown) and TGF-b1 (Figure
7b). Normal levels of TGF-b1, which is implicated in the
regulation of matrix deposition and wound contraction by
promoting myofibroblast differentiation (Tomasek et al.,
2002), also agreed with normal collagen organization and
abundance of a-smooth muscle actin expressing fibroblasts in
junBD/D wounds (Figure S2).
In summary, we found a strongly extended window of
elevated mRNA levels of four junB-dependent cytokines. As
kgf and tgf-b1 did not follow this pattern, one could assume
that these changes in cytokine expression are not a mere
consequence of the decelerated wound healing.
DISCUSSION
In this study, we describe the skin phenotype of mice, which
lack junB expression in the whole skin including dermal
fibroblasts, epithelial keratinocytes, and leukocytes. These
mice survive to adulthood and show a normal cutaneous
architecture, but exhibited a dramatic skin phenotype in junB
mutant mice in response to wounding or TPA treatment.
Under these conditions, the skin of junBD/D mice was
characterized by epidermal hyperproliferation, perturbed
keratinocyte differentiation, and enhanced inflammation.
These phenotypic alterations correlated with alterations in
the expression levels and kinetics of different JunB-dependent
epithelial growth factors, cytokines and chemoattractants,
and a reduced ability of mutant dermal fibroblasts to contract
collagen lattices in vitro.
As JunB is essential for placental vascularization during
early embryonic development (Schorpp-Kistner et al., 1999),
conditional junB-deficient mice were generated. The efficient
deletion of the junB gene in many organs of COL1A2-junB
mice was surprising, as COL1A2-Cre expression is predomi-
nantly found in mesenchymal cells leading to cell type-
specific deletion of floxed sequences, such as the flanking
region of the b-gal gene in the ROSA26R mouse strain (Florin
et al., 2004a). However, as described previously (Vooijs
et al., 2001; Korets-Smith et al., 2004), floxed genes differ in
the accessibility for Cre. The genomic locus of the junB,
which, according to its transcriptional regulation of an
immediate-early gene, is easily accessible and may therefore
represent a class of gene loci, where only very low levels of
Cre are required for efficient deletion.
Regardless of the mechanism of deletion, COL1A2-Cre
junB mice are viable but of reduced size and body weight,
which most likely emerges as a consequence of the complete
deletion of junB in the bone. Impaired JunB expression was
shown to be associated with decreased proliferation of
growth plate chondrocytes as well as defects in proliferation
and differentiation of osteoblasts, which together resulted in a
reduction of the overall bone mass (Hess et al., 2003; Kenner
et al., 2004).
In the in vitro wound healing model of organotypic co-
cultures, JunB activity in fibroblasts was shown to impact
critically on proliferation and differentiation of keratinocytes
(Szabowski et al., 2000). Accordingly, an obvious phenotype
arose after challenge of the skin by the phorbol ester TPA or
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wounding. Both stimuli, which are known triggers of AP-1
activity (Angel and Karin, 1991; Gallucci et al., 2000),
induced epidermal hyperproliferation, impaired keratinocyte
differentiation, and enhanced inflammatory response. Nota-
bly, hyperproliferation and irregular keratinocyte differentia-
tion have similarly been observed in organotypic co-cultures
in vitro (Szabowski et al., 2000). Here, JunB–deficiency, only
in fibroblasts, was sufficient to evoke abnormal epithelializa-
tion through de-regulated expression of paracrine-acting
factors. On the other hand, exclusive deletion of junB in
epidermal keratinocytes using K5-Cre mice also resulted in
increased epithelial thickness after TPA treatment (R. Zenz
and E.F. Wagner, personal communication), suggesting that
the absence of junB in the keratinocytes itself might induce
the expression of genes, which participate cell-autonomously
to the observed phenotype. Based on these data and our
finding that upon TPA treatment expression profiles of JunB
target genes, such as gro1 and gm-csf, are altered both in the
dermal and epidermal compartment (Figure S3), it is tempting
to speculate that JunB is involved in the control of epithelial
architecture both through cell-autonomous functions as well
as disturbance of the dermal–epidermal interaction.
As suggested by the enhanced inflammation, leukocytes,
which are found in high numbers in the wound granulation
tissue as well as in TPA-treated skin, are likely to participate
in the establishment of the skin phenotype of JunB mutant
mice. Although not included in the co-culture system and
thus possibly not strictly required for the JunB-dependent
development of epidermal hyperplasia, infiltrating neutro-
phils contribute in vivo substantially to the expression of
chemokines and epidermal growth factors (for a review, see
Schroder, 1995; Gillitzer and Goebeler, 2001; Grazul-Bilska
et al., 2003). In junBD/D mice, circulating lymphocytes as well
as neutrophil granulocytes harbor the deleted junB allele
(data not shown). Thus, the prolonged presence of neutro-
phils in wounds as well as their increased abundance in TPA-
treated skin might either be explained by junB-dependent
changes in immune cell behavior or be the consequence of
an altered microenvironment resulting from JunB deficiency
in the dermis and epidermis.
To gain insight into the molecular mechanism, we
analyzed the expression of various chemoattractants and
known players in cutaneous wound healing such as Mip-2,
Gro-1, and Lcn-2 (Fahey, III et al., 1990; Nanney et al., 1995;
Florin et al., 2004b, respectively), which were either directly
or indirectly repressed by JunB. Accordingly, expression of
the cytokines Mip-2, Gro-1, Lcn-2, and GM-CSF was also
altered in vivo in junBD/D mice, showing enhanced basal
levels in unchallenged skin (gm-csf), a stronger induction in
TPA-treated skin (Figure 3b) and a delayed, but prolonged
and increased expression during wound repair (Figure 6).
Mip-2/CXCL2 and Gro-1/KC/Mgsa/CXCL1 belong to the
CXC-family of small inducible cytokines (Balkwill, 2004) and
are potent mediators of neutrophil migration and chemotaxis
(Schroder, 1995), and overexpression of either Gro-1 in
keratinocytes (Lira et al., 1994) or Mip-2 in gut epithelial cells
(Ohtsuka et al., 2001) was found to induce leukocyte
infiltration in the respective tissues. As both cytokines show
upregulated expression in the skin of junBD/D mice after TPA
treatment (Figure S3), it seems likely that they might be
causally related to the increased abundance of infiltrating
neutrophils under these conditions (Figure 3). During wound
healing, the expression kinetics of Mip-2 and Gro-1 is shifted
in junB mutant animals, which correlates with the delayed
appearance of neutrophils and may contribute to their
prolonged persistence in the wound bed (Figure 6b).
High levels of GM-CSF and the functional human
homolog of Gro-1, IL-8, have been measured in hyper-
proliferative skin diseases (Gearing et al., 1990; Pastore et al.,
1997) and both proteins were shown to exhibit a strong
mitogenic activity for keratinocytes in vitro and/or in vivo
(Olaniran et al., 1995; Rennekampff et al., 1997; Mann et al.,
2001). Moreover, the JunB-dependent cytokine Lcn-2 was
described to be strongly induced in hyperplastic psoriatic
lesions (Mallbris et al., 2002). Thus, it is tempting to speculate
that combined overexpression of several growth factors with
mitogenic activity, such as Gro-1, GM-CSF (and possibly Lcn-
2) in challenged skin of junBD/D mice influence the balance of
keratinocyte proliferation and differentiation and ultimately
constitute a hyperplastic phenotype, which might not be
achieved by enhanced expression of individual factors, such
as GM-CSF in unchallenged skin of JunB mutant mice.
Treatment of wounds with Gro-1 also led to a significant
reduction in wound contraction, which was discussed to
result either through a direct action of the chemokine on
myofibroblasts or an indirect mechanism (Rennekampff et al.,
1997). Thus, strongly enhanced and prolonged expression of
Gro1 in wounded mutant skin (Figure 7) and in cultured
fibroblasts (L. Florin and P. Angel, unpublished) may provide
a functional link to the reduced ability of JunB-deficient
fibroblasts to contract collagen lattices in vitro (Figure 5e).
However, wound contraction depends on various parameters
including expression of components of the ECM, receptors for
ECM components, and proteases required for ECM remodel-
ling (Tomasek et al., 2002) and many members of these
protein families have been proposed to depend on AP-1
(Angel et al., 2001; Florin et al., 2004b).
In summary, we demonstrated an important regulatory
function of JunB in the cutaneous stress response and skin
regeneration, which both require rapid changes in the
transcriptional program. Obviously, based on genetic data,
there is only little functional redundancy in the genetic
programs controlled by either JunB or another AP-1 member,
c-Jun. Studies in mice and Drosophila have established an
essential role of c-Jun, as well as its upstream regulator JNK,
as a positive regulator of EGFR-dependent signalling,
promotion of epithelial cell migration and cytoskeletion
rearrangement (Kockel et al., 2001; Li et al., 2003; Zenz
et al., 2003; Xia and Karin, 2004). In contrast, our data imply
that JunB can rather act as a negative regulator of keratinocyte
proliferation via repression of critical cytokines and positively
regulates fibroblast contraction by an as yet unknown
mechanism. However, it is important to note that simulta-
neous, but not individual, deletion of c-Jun and JunB in
keratinocytes of adult mice results in the spontaneous
development of psoriasis. This is associated with an onset
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of the two chemotactic proteins S100a8 and S100a9 before
the disease (Zenz et al., 2005) supporting the concept of both
antagonistic and cooperative functions of c-Jun and JunB in
inflammatory responses of the skin.
Taken together, our data show that the immediate-early
transcription factor JunB regulates the cellular stress response
by controlling a complex combination of growth factors and
chemokines, which by both, autocrine and paracrine
mechanisms modulate keratinocyte proliferation and differ-
entiation as well as leukocyte chemotaxis during cutaneous
inflammation and regeneration.
MATERIALS AND METHODS
Generation of mutant mice
Mice carrying the floxed junB allele (junBflf) (Kenner et al., 2004)
were bred with COL1A2-Cre transgenic mice (Florin et al., 2004a) to
create COL1A2-Cre junBf/þ mice. Alternatively, junBf/ mice
harboring an inactive JunB-NEO fusion (Schorpp-Kistner et al.,
1999) were used to obtain COL1A2-Cre junBþ / offspring. Condi-
tional knockout mice (COL1A2-Cre junBf/ or f/f) were obtained in a
second mating with homozygous junBf/f mice. COL1A2-Cre mice
and junB floxed mice were backcrossed into C57BL/6 background
for at least three generations.
Genotyping by Southern blot and PCR analysis
For Southern blot analysis, genomic DNA of whole organs was
prepared; the epidermis and dermis were separated by thermolysin
treatment (Sigma, Deisenhofen, Germany). DNA (15 mg) was
digested with PstI, yielding fragments of 2.6 kb for the floxed junB
allele, 1.4 kb for the junB-Neo fusion, and 1.3 kb for the deleted junB
locus. Bands were detected using a 176 bp PstI/HindIII fragment of
the junB promoter as a probe. Primer sequences are listed in the
Table S1.
TPA-induced hyperproliferation
Age-matched 10 to 12-week-old junB mutant and control mice
(n¼ 4 per genotype) were shaved and, after 24 hours, treated three
times every 48 hours with 10 nmol TPA/100 ml or solvent alone
(acetone). Twenty-four hours after the last treatment, the skin was
isolated and either fixed in 4% paraformaldehyde/phosphate-
buffered saline at 41C overnight and embedded in paraffin for
histological sections or taken for RNA analyses.
Wound healing experiments
Four round full-thickness excisional wounds of 4 mm diameter were
generated in the back skin of anesthetized female junBD/D mice
(n¼ 30) and control littermates (n¼ 29) using sterile biopsy punches.
The wounds were left untreated. The mice were killed at different
time points after injury and wounds were either embedded for
sectioning or excised including 2 mm of the epidermal margins for
RNA isolation. Three animals and 3–7 wounds were analyzed per
genotype and time point. Granulation tissue volume and epidermal
thickness were measured using Adobes Photoshop software,
quantification of total cell numbers, neutrophils and macrophages
was performed using analySISs software. The animal experiments
were performed in accordance with the guidelines of the ATBW
(officials for animal welfare) and were approved by the Regierungs-
pra¨sidium Karlsruhe, Germany.
Immunohistochemistry, immunofluorescence, and
collagen-staining
Paraffin sections (7 mm) of mouse back skin and cryosections of
wounds were stained with hematoxylin and eosin or analyzed by
immunological methods. Immunohistochemistry was performed
using the following primary antibodies: JunB (C-11, #sc-8051 and
N-17, #sc-46, Santa Cruz Biotechnology Inc., Santa Cruz, CA), Ki67
(Novocastra, Newcastle upon Type, UK), Keratin 6, K10 and Loricrin
(BabCo, Freiburg, Germany), CD68 and Neutrophils (Serotec,
Duesseldorf, Germany). Bisbenzimide dye (Hoechst No. 33258)
was used for nuclear counterstaining. Collagen organization was
estimated on cryosections (5mm) of wounds that were stained with
Picrosirius red (Junqueira et al., 1979) and imaged on a Zeiss
Axioplan microscope. Images were captured using a Hamamatsu 3
CCD cooled camera (Hamamatsu, Hamamatsu City, Japan) and
Simple PCI imaging software (Compix Imaging Systems, Pittsburgh,
PA).
RNA isolation and RT-PCR
Total RNA was isolated using TRIzols reagent (Invitrogen GmbH,
Karlsruhe, Germany) according to standard protocols followed by
treatment with DNAse I for 30 minutes at 371C. Quantitative
differences in gene expression were determined by real-time RT-
PCR using the AbsoluteTM QPCR SYBRs Green Fluorescein Mix
(ABgene, Surrey, UK) and a thermal cycler controlled by the MyiQ
Real Time Detection System software (BioRad, Munich, Germany).
All experiments were performed at least in triplicates. For
semiquantitative RT-PCR, gene-specific fragments were obtained
by linear phase PCR-amplification and standardized for hprt levels.
Primer sequences are listed in the Table S1.
Collagen contraction assay
Adult (12 weeks old) junB mutant and control animals were
euthanized by decapitation. Back skin was removed and the dermis
separated after incubation for 2 hours on thermolysin at room
temperature. To isolate primary fibroblasts, the dermis was diced
finely and incubated with 1 mg/ml Collagenase D (Boehringer
Mannheim, Germany) for 2–3 hours at 371C. Tissue debris was
removed by centrifugation and collected fibroblasts were cultured in
DMEM (Invitrogen, Karlsruhe, Germany) containing 20% FCS (PAA
Laboratories, Co¨lbe, Germany), 2 mM glutamine, and antibiotics
(Seromed-Biochrom, Berlin, Germany). The fibroblasts were used
between passages 2 and 4 for experiments.
Three-dimensional collagen gels were prepared as described
previously (Mauch et al., 1988). Briefly, type I collagen (3 mg/ml,
Vitrogen) and 10 DMEM were combined in a 10:1 ratio and
neutralized by the addition of 0.1 M NaOH. Fibroblasts were seeded
into collagen gels at a density of 2.5 105 cells/ml and incubated at
371C. After 2 hours incubation, gels were gently detached from the
plates and contraction monitored over time.
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SUPPLEMENTARY MATERIAL
Table S1. Oligonucleotide sequences used for PCR analyses.
Figure S1. COL1A2-Cre x junB mice show a reduced body size and lower
body weights. (a) A 3 month-old conditional junB mutant (junBD/D) mouse and
a control littermate are shown. (b) Reduced body weight of male and female
junB mutant (black dots) compared to controls (open circles). Larger circles
indicate the mean values of control (n¼ 12) and mutant animals (n¼ 11).
Figure S2. Analysis of the granulation tissue (a) Collagen was stained with
picrofuchsin to examine matrix organization as measured by the distribution
of total collagen (BF, brightfield) versus highly organized collagen fibres (PC,
phase contrast). Scale bar¼100 mm. (b) Immunohistochemical staining for a-
SMA detected comparable amounts of myofibroblasts in wounds of junBD/D
mice and controls at day 5. Scale bar¼ 100mm. Lower panel: Higher
magnification of a-SMA positive cells. Scale bar¼ 20 mm
Figure S3. Contribution of the dermal and epidermal compartment to cytokine
expression. (a) Semi-quantitative RT-PCR and (b) real-time PCR on RNA from
separated dermis and epidermis of untreated () and TPA treated (þ , three
consecutive applications every 48 hours) control (n¼2) and junB mutant
mice (n¼ 4) revealed both dermal and epidermal cells as source of de-
regulated expression of JunB dependent cytokines. Collagen type I-alpha2
(col1a2) was used as control for tissue separation. cDNA levels were
standardized to hprt quantities. Error bars in (b) indicate the mean7SEM of
triplicate experiments.
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